S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Genesis Healthcare Stock Forecast, Price & News

-0.02 (-2.68 %)
(As of 01/15/2021 12:00 AM ET)
Today's Range
Now: $0.73
50-Day Range
MA: $0.55
52-Week Range
Now: $0.73
Volume4.58 million shs
Average Volume3.83 million shs
Market Capitalization$121.01 million
P/E RatioN/A
Dividend YieldN/A
Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of April 23, 2020, it provided inpatient services through a network of approximately 400 skilled nursing facilities and assisted/senior living communities in 25 states; and supplied rehabilitation and respiratory therapy to approximately 1,200 healthcare locations in 44 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.
Genesis Healthcare logo


Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 1.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Skilled nursing care facilities



Sales & Book Value

Annual Sales$4.57 billion
Cash Flow$0.79 per share
Book Value($6.57) per share


Net Income$14.62 million


Market Cap$121.01 million
Next Earnings Date3/15/2021 (Estimated)
-0.02 (-2.68 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Genesis Healthcare (NYSE:GEN) Frequently Asked Questions

How has Genesis Healthcare's stock price been impacted by COVID-19?

Genesis Healthcare's stock was trading at $1.16 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GEN shares have decreased by 37.5% and is now trading at $0.7255.
View which stocks have been most impacted by COVID-19

Is Genesis Healthcare a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Genesis Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GEN, but not buy additional shares or sell existing shares.
View analyst ratings for Genesis Healthcare
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Genesis Healthcare?

Wall Street analysts have given Genesis Healthcare a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Genesis Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Genesis Healthcare's next earnings date?

Genesis Healthcare is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021.
View our earnings forecast for Genesis Healthcare

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare, Inc. (NYSE:GEN) issued its quarterly earnings data on Monday, November, 9th. The company reported ($0.55) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.53. The company earned $938.65 million during the quarter. Genesis Healthcare had a negative net margin of 1.52% and a negative return on equity of 5.06%.
View Genesis Healthcare's earnings history

What price target have analysts set for GEN?

1 analysts have issued 12-month price targets for Genesis Healthcare's shares. Their forecasts range from $0.57 to $0.57. On average, they anticipate Genesis Healthcare's stock price to reach $0.57 in the next year. This suggests that the stock has a possible downside of 21.4%.
View analysts' price targets for Genesis Healthcare
or view Wall Street analyst' top-rated stocks.

Are investors shorting Genesis Healthcare?

Genesis Healthcare saw a decrease in short interest in the month of December. As of December 31st, there was short interest totaling 539,000 shares, a decrease of 26.4% from the December 15th total of 732,000 shares. Based on an average daily volume of 1,310,000 shares, the short-interest ratio is currently 0.4 days. Currently, 1.0% of the shares of the stock are short sold.
View Genesis Healthcare's Short Interest

Who are some of Genesis Healthcare's key competitors?

What other stocks do shareholders of Genesis Healthcare own?

Who are Genesis Healthcare's key executives?

Genesis Healthcare's management team includes the following people:
  • Mr. George V. Hager Jr., CEO & Director (Age 64, Pay $941.61k)
  • Mr. Thomas DiVittorio, Exec. VP & CFO (Age 52, Pay $525k)
  • Mr. Paul David Bach, COO & Exec. VP (Age 61, Pay $525k)
  • Mr. Michael Scott Sherman, Sr. VP, Gen. Counsel, Sec. & Assistant Treasurer (Age 51, Pay $380k)
  • Dr. JoAnne Susan Reifsnyder R.N., Ph.D., MSN, MBA, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 61, Pay $425k)
  • Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 65)
  • Mr. James W. Tabak, Sr. VP of Admin. & Gov. Affairs (Age 61)
  • Ms. Lori Mayer, VP of Investor Relations, Brand Management & Marketing Communications
  • Mr. Larry Baider, Sr. VP of People Strategy & Operations
  • Mr. Jason Hadley Feuerman, Sr. VP of Strategic Devel. & Managed Care

What is Genesis Healthcare's stock symbol?

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

How do I buy shares of Genesis Healthcare?

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Genesis Healthcare's stock price today?

One share of GEN stock can currently be purchased for approximately $0.73.

How big of a company is Genesis Healthcare?

Genesis Healthcare has a market capitalization of $121.01 million and generates $4.57 billion in revenue each year. Genesis Healthcare employs 55,000 workers across the globe.

What is Genesis Healthcare's official website?

The official website for Genesis Healthcare is www.genesishcc.com.

How can I contact Genesis Healthcare?

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.